Thévenod Frank, Herbrechter Robin, Schlabs Carolin, Pethe Abhishek, Lee Wing-Kee, Wolff Natascha A, Roussa Eleni
Institute for Physiology, Pathophysiology and Toxicology, Center for Biomedical Education and Research, Witten/Herdecke University, Witten, Germany.
Physiology and Pathophysiology of Cells and Membranes, Medical School OWL, Bielefeld University, Bielefeld, Germany.
Am J Physiol Renal Physiol. 2023 Nov 1;325(5):F564-F577. doi: 10.1152/ajprenal.00020.2023. Epub 2023 Aug 17.
The transmembrane protein SLC22A17 [or the neutrophil gelatinase-associated lipocalin/lipocalin-2 (LCN2)/24p3 receptor] is an atypical member of the SLC22 family of organic anion and cation transporters: it does not carry typical substrates of SLC22 transporters but mediates receptor-mediated endocytosis (RME) of LCN2. One important task of the kidney is the prevention of urinary loss of proteins filtered by the glomerulus by bulk reabsorption of multiple ligands via megalin:cubilin:amnionless-mediated endocytosis in the proximal tubule (PT). Accordingly, overflow, glomerular, or PT damage, as in Fanconi syndrome, results in proteinuria. Strikingly, up to 20% of filtered proteins escape the PT under physiological conditions and are reabsorbed by the distal nephron. The renal distal tubule and collecting duct express SLC22A17, which mediates RME of filtered proteins that evade the PT but with limited capacity to prevent proteinuria under pathological conditions. The kidney also prevents excretion of filtered essential and nonessential transition metals, such as iron or cadmium, respectively, that are largely bound to proteins with high affinity, e.g., LCN2, transferrin, or metallothionein, or low affinity, e.g., microglobulins or albumin. Hence, increased uptake of transition metals may cause nephrotoxicity. Here, we assess the literature on SLC22A17 structure, topology, tissue distribution, regulation, and assumed functions, emphasizing renal SLC22A17, which has relevance for physiology, pathology, and nephrotoxicity due to the accumulation of proteins complexed with transition metals, e.g., cadmium or iron. Other putative renal functions of SLC22A17, such as its contribution to osmotic stress adaptation, protection against urinary tract infection, or renal carcinogenesis, are discussed.
跨膜蛋白SLC22A17 [或中性粒细胞明胶酶相关脂质运载蛋白/脂质运载蛋白-2 (LCN2)/24p3受体] 是有机阴离子和阳离子转运体SLC22家族的一个非典型成员:它不运载SLC22转运体的典型底物,而是介导LCN2的受体介导的内吞作用 (RME)。肾脏的一项重要任务是通过近端小管 (PT) 中巨膜蛋白: 立方蛋白: 无羊膜蛋白介导的内吞作用对多种配体进行大量重吸收,以防止肾小球滤过的蛋白质经尿液流失。因此,如范科尼综合征那样的溢流、肾小球或PT损伤会导致蛋白尿。值得注意的是,在生理条件下,高达20% 的滤过蛋白会逃过PT,并被远端肾单位重吸收。肾远端小管和集合管表达SLC22A17,它介导逃过PT的滤过蛋白的RME,但在病理条件下预防蛋白尿的能力有限。肾脏还能防止滤过的必需和非必需过渡金属 (如铁或镉) 排出,这些金属在很大程度上与高亲和力蛋白 (如LCN2、转铁蛋白或金属硫蛋白) 或低亲和力蛋白 (如微球蛋白或白蛋白) 结合。因此,过渡金属摄取增加可能会导致肾毒性。在此,我们评估关于SLC22A17结构、拓扑结构、组织分布、调控及假定功能的文献,重点关注肾脏中的SLC22A17,它因与过渡金属 (如镉或铁) 络合的蛋白质积累而与生理学、病理学及肾毒性相关。还讨论了SLC22A17其他假定的肾脏功能,如它在适应渗透压应激、预防尿路感染或肾致癌作用中的作用。